Merve Çakmak

Merve Çakmak

Auto-generated profile, based on publicly available information

Merve Çakmak

Department of Pediatric Neurology, University of Health Sciences Turkey, Basaksehir Cam and Sakura City Hospital, Istanbul, Turkey

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 February 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
SMSevinc Mertoglu
Sevinc Mertoglu
MÇMerve Çakmak
Merve Çakmak
ZDZeynep Öz Dağdelen
Zeynep Öz Dağdelen
SISibel Fulya Ekici Ibrahimoğlu
Sibel Fulya Ekici Ibrahimoğlu
ASAyşe Sandıkkaya
Ayşe Sandıkkaya
IKIhsan Kafadar
Ihsan Kafadar
GBS is an acute immune-mediated neuropathy and a leading cause of acute flaccid paralysis in children. Although intravenous immunoglobulin and plasmapheresis are established treatments, data comparing their outcomes and prognostic factors in pediatric patients remain limited.Objective: To evaluate clinical characteristics, treatment modalities, and prognostic factors in pediatric GBS, with a focus on functional outcomes assessed by the Hughes disability score.Methods: This retrospective observational study included children diagnosed with GBS and treated with either IVIG alone or IVIG combined with plasmapheresis. Demographic features, clinical presentation, antecedent infections, cerebrospinal fluid protein levels, electrophysiological subtypes, lumbar MRI findings, rehabilitation duration, PICU admission, mechanical ventilation requirement, and neurological sequelae were analyzed. Functional status was assessed using the Hughes disability scale at admission and at 3 months. Correlation analyses were performed to evaluate associations between Hughes scores and clinical parameters.Results: Thirty-two pediatric patients were included; 27 received IVIG alone and 5 received IVIG plus plasmapheresis. No significant differences were observed between treatment groups regarding age, CSF protein levels, or rehabilitation duration, although rehabilitation tended to be longer in the combination therapy group. PICU admission and mechanical ventilation occurred exclusively in patients receiving IVIG plus plasmapheresis. At 3 months, patients with Hughes scores >2 had significantly higher rates of residual neurological deficits (75% vs. 0%, p=0.001). Rehabilitation duration showed a strong positive correlation with the 3-month Hughes score (r=0.737, p=0.001).Conclusion: Higher 3-month Hughes scores were associated with residual neurological deficits and longer rehabilitation duration. Treatment modality was not independently associated with short-term functional outcome.

27 November 2025 in Child's Nervous System
Verified
Journal Article
Closed access
PDF file
MÇMerve Çakmak
Merve Çakmak
MKMehmet Karagülle
Mehmet Karagülle
FKFatma Selin Kaya
Fatma Selin Kaya
PAPınar Arıcan
Pınar Arıcan
PPPeren Perk
Peren Perk
IKİhSan Kafadar
İhSan Kafadar

21 September 2024
Verified
Book
Open access
PDF file
YGYiğithan Güzin
Yiğithan Güzin
AÜAycan Ünalp
Aycan Ünalp
SÖSemra Büyükkorkmaz Öztürk
Semra Büyükkorkmaz Öztürk
MAMüge Ayanoğlu
Müge Ayanoğlu
FHFatma Hancı
Fatma Hancı
FSF. Müjgan Sönmez
F. Müjgan Sönmez

21 September 2024
Verified
Book Chapter
Closed access
MÇMerve Çakmak
Merve Çakmak
PPPeren Perk
Peren Perk
IKİhSan Kafadar
İhSan Kafadar
Hipokampal sklerozlu mezial temporal lob epilepsisi (HS), özellikle çocukluk çağında, uzun süreli febril nöbetler veya febril status epileptikus nedeniyle hipokampal alanda skleroz ile karakterize spesifik bir epilepsi sendromudur. Hastalığın temel özelliği genellikle erişkinlik döneminde başlayan fokal nöbetlerdir. Bununla birlikte, nöbetler rutin antiepileptik ilaç tedavisine dirençlidir. Klinik bulgular, elektroensefalogram değişiklikleri ve spesifik görüntüleme bulguları iyi tanımlanmıştır. Bazı kişilerde nöbetlerin medikal tedaviye yanıt vermemesi nedeniyle cerrahi rezeksiyon seçeneklerine ihtiyaç duyulabilir. HS'nin altta yatan etiyolojisi hala belirsizliğini korumakta. Yeni nesil genetik çalışmaların ve deneysel modellerin gğncel tedavi seçeneklerini geliştireceğini düşünüyoruz. Mesial temporal lobe epilepsy with hippocampal sclerosis (HS) is a specific epilepsy syndrome characterized by sclerosis in the hippocampal area resulted from prolonged febrile seizures or febrile status epilepticus, especially in the childhood. The main feature of disease is focal seizures onset usually adulthood period. However, seizures are resistant to routine antiepileptic drugs treatment. The clinical findings, electroencephalogram changes and specific imaging findings are well identified. Surgical resection options may be needed in some individuals due to the seizures unresponsive to medical treatment. The underlying etiology of HS is still unclear. We think that next generation genetic studies and experimental models will develop new treatment options.